Shire
Shire Pharmaceuticals Ireland is involved in the research, development and marketing of prescription medicines. Its particular focus is medicines for attention deficit hyperactivity disorder, human genetic therapies and gastrointestinal diseases. It employs 119 people in Dublin and is part of Swiss company Shire AG.
Shire made its biggest ever acquisition yet in January 2015 with a $5.2 billion deal for US biotechnology company NPS Pharmaceuticals. The move came a few months after the group's sale to rival AbbVie collapsed.
Financial Data
-
31st Dec 17 Source: CRO
- €12.4 billion turnover
-
€3.5 billion
profit - 22,000 employees
-
31st Dec 16 Source: CRO
- €1.6 billion turnover
-
€115.2 million
profit - 109 employees
- 9 more years available »
Ranking
By Turnover
(€12.4 billion)- 9th in Top Companies
- 2nd in Pharma
By Employees
(22,000)- 7th in Top Companies
- 1st in Pharma
-
- 22,000
- €12.4 billion
Employees
- Flemming Ornskov CEO/Managing Director
Latest News
- 5:55am Uber’s e-bike plan for Dublin rejected on safety grounds
- 5:30am Center Parcs set to go wild at ‘subtropical’ Longford resort
- Feb 22 Carbery to extend cheese production into mozzarella
- Feb 22 UBS sticks to dividend, capital return plans after French verdict
- Feb 22 Markets optimistic over US-China trade row breakthrough hopes